Release Date: 30/07/09 08:24 Summary: Notice of Change in Substantial Holding Price Sensitive: No Download Document 56.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%